Skip to content

Common Stock at other companies

Stryker logo
StrykerSYK
$38M0.0%
Vericel logo
VericelVCEL
75M0.0%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$3.2M0.0%
Pacira BioSciences, Inc. logo
Pacira BioSciences, Inc.PCRX
250M0.0%
Xtant Medical Holdings logo
Xtant Medical HoldingsXTNT
300M0.0%
Globus Medical logo
Globus MedicalGMED

Other financials

Income statement

See full
Revenue$29.6M+13.2%
Net income-$5.1M-3.8%

Balance sheet

See full
Cash & equivalents$41.0M-23.1%
Total debt$25.7M+1.2%
Total equity$133.9M-9.8%
Total assets$179.4M-5.9%

Cash flow

See full
Operating cash flow-$4.8M-3,628%
CapEx$1.4M-49.3%
Free cash flow-$6.3M-112%

Valuation

See full
Market cap$204.37M+31.6%
Enterprise value$189.09M+48.7%
P/S1.8×+0.1×

Profitability

See full
Net margin-9.8%-4.4pp
FCF margin0.9%

Returns & leverage

See full
Return on equity-8%-3.4pp
Debt / equity0.2×0.0×
Current ratio4.5×-1.3×

Where this comes from

Reported directly by Anika Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The official record: Anika Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Anika Therapeutics's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Anika Therapeutics's common stock?
Anika Therapeutics (ANIK) reported common stock of $133K in Q1 2026.
How has Anika Therapeutics's common stock changed year-over-year?
Anika Therapeutics's common stock decreased by 7.0% year-over-year, from $143K to $133K.
What is the long-term trend for Anika Therapeutics's common stock?
Over 5 years (2020 to 2025), Anika Therapeutics's common stock has grown at a -0.6% compound annual growth rate (CAGR), from $143K to $139K.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).